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The innate immune system provides the first line of defense
against invading microorganisms by inducing a variety of
inflammatory and antimicrobial responses. These responses
are particularly important in the gastrointestinal tract, where
the needs for efficient nutrient uptake and host defense
collide. Many pathogens have evolved to specifically colonize
the intestine, causing millions of cases of enteric infections a
year. A paradigm of an enteric pathogen is Salmonella enterica,
a gram-negative bacterium that causes a wide range of gastro-
intestinal and systemic diseases. Infections with Salmonella
enterica serovar Typhimurium (S. typhimurium) lead to an acute
intestinal inflammation in human and animal hosts, as a result
of the bacterium invading the mucosa. A distinctive feature of
Salmonella is that it has not only adapted to survive in a strong
inflammatory environment, but it also uses this adaptation as
a strategy to gain a growth advantage over the intestinal
microbiota. We will use the model organism S. typhimurium to
discuss the innate immune mechanisms employed by the
mammalian gastrointestinal system and how the pathogen
responds and subverts these mechanisms. In particular, we
focus on the recognition of extra- and intra-cellular
Salmonellae by germline-encoded pattern recognition
receptors of the TLR and NLR families, and how Salmonella
might profit from the activation of these receptors.
Innate Immunity
The innate immune system comprises many different mechanisms
and components that act in a coordinated fashion to restrict an
infection and eliminate the invading pathogen. A diverse array of
immune cells cooperate in the rapid recognition and elimination
of invading microbes through phagocytosis-mediated killing and
the induction of inflammation.
1 Acute inflammation is character-
ized by an increased blood flow, rapid influx and activation of
immune cells, and the release of pro-inflammatory cytokines. This
results in heat, swelling and redness of the affected area and serves
to prevent the spread of the infection and to promote pathogen
clearance and tissue repair. The inflammatory response needs to
be tightly regulated and quickly terminated to prevent unneces-
sary damage to tissues and to the organism.
Over the past decade, compelling evidence has demonstrated
that detection of invading microbes is based on germline-encoded
pattern-recognition receptors (PRRs), which recognize conserved
microbial molecules, called pathogen- associated molecular
patterns (PAMPs).
2 In addition to PAMPs, PRRs also respond
to endogenous, host-derived danger signals, termed DAMPs
(Danger-associated molecular patterns) or alarmins, which are
released in response to tissue injury, stress or necrotic cell death.
Several families of pattern-recognition receptors have been
discovered thus far and are known to engage in the surveillance
of both the extracellular and intracellular space. These families
include the membrane-bound Toll-like receptors (TLRs) and
C-type lectins that recognize PAMPs/DAMPs in the extracellular
compartment and in endosomes, and recognize the cytosolic
NOD-like receptors (NLRs), PYHIN-proteins and RIG-I-like
receptors (RLRs) that monitor the intracellular space. These
receptors allow the discrimination of various types of tissue insults
and launch appropriate inflammatory responses.
The Gastrointestinal Immune System
The immune system is particularly important in the gastro-
intestinal (GI) tract, since it is the location where the divergent
needs of nutrient absorption and host defense collide. The former
requires a large surface area and a thin epithelium, which in turn
has the potential to compromise host defenses. It is therefore not
surprising that many pathogens have evolved to take advantage
of this apparent impairment. The importance of protecting the
gut from these pathogens is evident in the abundance of lym-
phoid tissue and immune cells it harbors. Yet, the most difficult
challenge that the gastrointestinal immune system has to face is to
respond to pathogens while remaining relatively unresponsive to
food antigens and the commensal microflora. The need for tight
control of the inflammatory response and the maintenance of gut
homeostasis is highlighted by the severity of chronic auto-
inflammatory bowel diseases, such as Crohn disease and ulcerative
colitis (UC).
3
The primary cellular barrier of the gut is a single layer of
intestinal epithelial cells, which are critical for nutrient uptake yet
provide a physical and chemical barrier (Fig.1). This gastro-
intestinal barrier not only blocks the entry of commensals and
*Correspondence to: Denise M. Monack; Email: dmonack@stanford.edu
Submitted: 11/15/11; Revised: 12/16/11; Accepted: 12/21/11
http://dx.doi.org/10.4161/gmic.19141
Gut Microbes 3:2, 62–70; March/April 2012; G 2012 Landes Bioscience
62 Gut Microbes Volume 3 Issue 2© 2012 Landes Bioscience.
Do not distribute.
pathogens, but also normally prevents the innate immune system
from encountering commensal-derived antigens. Each epithelial
cell maintains intimate association with its neighbors and seals the
surface of the gut with tight junctions. Non-hematopoietic cells
in the epithelial layer help to maintain this barrier by secreting
mucus (goblet cells) or antimicrobial peptides (Paneth cells)
(Fig.1). Underlying this epithelial cell layer is the lamina propria,
which contains a highly organized lymphoid tissue commonly
referred to as gut-associated lymphoid tissue (GALT). The GALT
is comprised of isolated and aggregated lymphoid follicles and is
populated by a wide array of lymphocytes, such as T cells and B
cells, dendritic cells, macrophages and neutrophils (Fig.1). These
cells regulate inflammatory responses to bacteria and antigens that
breach the gastrointestinal barrier, protect the mucosa against
harmful pathogens, and scavenge dead cells and foreign debris.
Aggregated lymphoid follicles, so-called Peyer’s patches (PP), are
surrounded by a particular epithelium, the follicle-associated
epithelium (FAE), which forms the interface between the GALT
and the luminal microenvironment. The PPs have an important
role in the immune surveillance of the intestinal lumen and
facilitate the induction of defense against pathogens or immune
tolerance (oral tolerance) as a result of the complex interplay
between immune cells located in the lymphoid follicles and the
FAE. The FAE contains specialized cells named M (for micro-
fold) cells, which transport luminal antigens and bacteria to the
basolateral side by transcytosis. At their basal surface, the cell
membrane of M cells is extensively folded around underlying
lymphocytes and antigen-presenting cells that activate or inhibit
the immune response leading to either tolerance or systemic
immune responses. In addition, antigen-presenting dendritic cells
(DCs) send processes between intestinal epithelial cells without
disturbing tight junction integrity and sample antigens from
commensal and pathogenic gut bacteria. B cells and memory cells
get activated by antigen-presenting cells in PPs and then travel to
the mesenteric lymph nodes (MLN), where the immune response
is amplified. Thus the GALT plays a crucial part in the interplay
between the innate and adaptive immune system.
Salmonella Infections
Salmonella enterica is a flagellated, Gram-negative, facultative
intracellular bacterial species that is a leading cause of enteric
Figure1. Schematic representation showing the different routes Salmonella can take in order to invade the intestinal mucosa. (1) The major pathway of
invasion is through M cell mediated transcytosis at the Peyer’s patches. (2) An alternative route is via uptake by enterocytes. (3) This route requires the
injection of bacterial effector proteins by the SPI-1 Type 3 Secretion System that induce ruffling and uptake of the bacterium. Uptake through
intercalating CX3CR1
+ macrophages/DCs might represent an additional route of invasion.
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disease in humans and in animal hosts. Salmonellae are taken up
via contaminated food and can infect a broad range of hosts;
certain host-adapted serovars can even cause a severe systemic
disease. For example, the human restricted S. enterica serovar
Typhi causes Typhoid fever, which affects over 20 million people
worldwide and leads to approximately 200,000 deaths per year.
In contrast, S. enterica serovar Typhimurium (S. typhimurium)
causes a self-limiting gastroenteritis in humans, while mice
infected with this serovar get a systemic disease with a patho-
genesis resembling typhoid fever in humans. Thus murine
infections with S. typhimurium are studied as a model for human
Typhoid infections. Interestingly the disease outcome varies
significantly between different inbred mouse strains. C57BL/6
mice get an acute infection leading to death within 6–8 d post-
infection; 129Sv mice contain the infection and can become
persistently infected,
4 which is reminiscent of S. typhi infections.
Humans with Typhoid can become persistently infected once the
initial acute phase has subsided, and this population serves as a
significant reservoir for disease transmission.
After being ingested with contaminated food, Salmonellae
reach the gut lumen where they have to compete with the resident
intestinal microbiota for nutrients. Colonization resistance is
provided by the indigenous commensals and is an important but
often overlooked barrier to infection with enteric pathogens.
Treatment with an antibiotic such as streptomycin before the
infection has been shown to reduce the infectious dose of
S. typhimurium in mice by . 100,000-fold and is therefore
commonly used in some mouse models of Salmonella infection
to circumvent colonization resistance.
5 Importantly, several
groups have demonstrated that S. typhimurium uses its virulence
factors to induce intestinal inflammation during the intestinal
phase to gain a growth advantage over the microbiota. For
example, reactive oxygen species generated during inflammation
react with endogenous, luminal sulfur compounds (thiosulphate)
to form a new respiratory electron acceptor, tetrathionate, which
S. typhimurium has evolved to use, while commensals lack the
required metabolic pathways.
6
There are two main components to Salmonella infections in
the intestine: adherence and subsequent invasion.
7 Several
adhesins and fimbriae are necessary to mediate adherence to
epithelial cells in the gut.
8 Following adherence, Salmonella
can use several different mechanisms to cross the intestinal
epithelium. (Fig.1.) A major route of entry is through M cells in
the FAE overlying PPs, which transport antigens and bacteria
from the lumen to the lamina propria.
9 Salmonella can also
induce its internalization in non-phagocytic enterocytes through
its virulence-associated type 3 secretion system encoded by
Salmonella pathogenicity Island 1 (SPI-1).
10 Invasion also has
been proposed to occur by paracellular pathways following
disruption of tight junctions
11 or via CX3CR1
+ macrophages/
DCs, which intercalate between epithelial cells.
12-14 However, the
importance of these invasion-independent alternative pathways
remains to be determined.
After crossing the intestinal barrier at the site of PPs, the
bacteria are taken up by phagocytic immune cells like macro-
phages. Once phagocytosed, Salmonellae replicate within a
vacuolar compartment in the cytoplasm.
7 Crucial for this intra-
cellular phase is a second type 3 secretion system encoded by
Salmonella pathogenicity Island 2 (SPI-2). While non-typhoidal
strains remain restricted to the GI tract, typhoidal Salmonella
serovars then disseminate from the GI tract to mesenteric lymph
nodes and colonize systemic sites, like the liver and spleen.
Innate Immune Response to Salmonella
Salmonella is a very successful enteric pathogen because it has
developed strategies to cope with most of the immune defenses
employed by the host during the different phases of the disease.
In the following we will describe in detail the innate immune
mechanisms employed by the host and how Salmonella reacts to
and subverts these immune responses.
Gastric innate immune mechanisms. One of the first obstacles
faced by Salmonella is a thick layer of mucous that covers the
surface of the gut epithelium and provides an initial barrier,
which must be penetrated in order to gain direct contact with the
epithelium. This mucus layer is formed by mucins, a family of
glycoproteins secreted by specialized types of epithelial cells,
called Goblet cells (Fig.1). In addition to the mucins, cells in
the gastrointestinal tract secrete several types of antimicrobial
peptides, which are small amphipathic proteins that function like
peptide antibiotics by disrupting the integrity of the bacterial cell
membrane. The production and release of antimicrobial peptides
and mucins by the epithelial cells of the gut represents a major
barrier against microbial invasion and an important part of the
innate immune response. While some antimicrobial peptides
are expressed constitutively, many are induced as part of the
inflammatory response to invading pathogens.
15 Paneth cells of
the intestinal crypts are the most abundant producers of con-
stitutively expressed antimicrobial peptides in mammals, such as
a- and β-defensins (cryptdins in mice), CRS peptides, lysozyme
and phospholipase A2 (sPLA2).
16 They can be induced to secrete
additional types of antimicrobial peptides, such as cathelicidins,
angiogenin 4 (ANG4) and the C-type lectins RegIIIβ/c
15,i n
response to microbial PAMPs. In addition to Paneth cells,
epithelial cells are also known to produce inducible antimicrobial
peptides such as RELM-b, RegIIIc, calprotectin and β-defensins.
During S. typhimurium infections of Streptomycin-pretreated
mice, RegIIIβ and RegIIIc expression is markedly increased.
17
RegIIIc secretion contributes to the clearance of other intestinal
pathogens such as Listeria monocytogenes and Enterococcus spp.
18
However, unlike these pathogens Salmonella is better adapted to
counter host defenses and might even profit from increased
production of C-type lectins to gain a growth advantage over
the microbiota. In vitro, RegIIIβ kills diverse commensal gut
bacteria but not Salmonella, which can be attributed to its specific
cell envelope structure.
19 RegIIIc production is absent in mice
deficient for MyD88, an adaptor of TLR signaling.
20 In addition
to TLRs, cytokines of the IL-23/IL-22 axis (see below) might
also be involved in the production of antimicrobial peptides
(Fig.2). In vitro, IL-22 is known to induce the expression of
inducible Nitric Oxide Synthase (iNOS), the mucin MUC4 and
the siderophore lipocalin-2 in human colonic epithelial cells.
21 In
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infections in the ileal mucosa of infected rhesus macaques.
Expression of iNOS, calprotectin, MUC4, Duox2 and enteric
β-defensins are all upregulated in the inflamed mucosa
22-24
(Fig.2). Since S. typhimurium infection of cultured colonic
epithelial cells does not induce the same response, it suggests that
paracrine IL-22 signaling is required. Consistently during
Citrobacter rodentium infections of mice, IL-22 is required for
the expression of RegIIIc and Calprotectin.
25
In order to overcome the chemical barrier generated by these
antimicrobial peptides, S. typhimurium has developed means to
sense these host responses or effectors and to respond by
upregulating corresponding virulence mechanisms. For example,
the PhoP-PhoQ two-component signal transduction system,
which Salmonella shares with many other bacteria, has been
shown to sense the presence of cationic antimicrobial peptides
as well as divalent cations and low pH.
26 Activation of PhoQ
induces a transcriptional program resulting in increased resistance
against antimicrobial peptides that is achieved by modifications
of lipid A either by acylation (PagP) or addition of an amino-
arabinose moiety (Pmr system). Salmonellae lacking PhoP or
PhoQ have been shown to be severely attenuated in an in vivo
model of infection and to confer partial protective immunity
against subsequent wild-type Salmonella infections.
27 Additional
resistance mechanisms to innate defenses in the gut include
expression of enzymes encoded by the iroBCDE iroN locus, which
alter the structure of the Salmonella Fe
+ binding protein Ent,
thereby preventing it from being bound and sequestered by
lipocalin-2.
28 Indeed, Salmonella mutants lacking iroN fail to
evade the scavaging effects of lipocalin-2 and are severely
attenuated for growth in the gut.
21
Detection of Salmonella by PRRs. Crossing the epithelial
barrier allows Salmonella to escape the inhospitable environment
at the surface of the intestinal mucosa and to evade many
antimicrobial defenses. However, once Salmonella has passed
through M cells or enterocytes, it encounters the next layer of
innate immune defenses, the monocyte-derived phagocytic cells
of the GALT: macrophages and dendritic cells. The main
function of these cells is to remove invading microbes by phago-
cytosis and to alert other immune cells of the infection, either
directly or by secreting pro-inflammatory cytokines. Following
phagocytosis, Salmonellae express their virulence-associated SPI-2
T3SS to establish themselves in an intracellular compartment
named the Salmonella containing vacuole (SCV).
7 Within this
compartment Salmonella can replicate to high numbers before
exiting the cell and infecting new host cells. Although Salmonella
remains partially hidden within its intracellular niche, it cannot
completely escape host cell sensing. All monocytic cells express an
array of germline-encoded pattern recognition receptors (PRR),
which enable them to detect pathogen-associated molecular
pattern molecules (PAMPs). Toll-like receptors (TLRs), which
are located on the outer membrane of the cell (TLR1, 2, 4, 5,
6, 10) or in intracellular vesicles (TLR3, 7, 8, 9, 11, 13 early and
late endosome, lysosomes), are the first PRRs to detect the
presence of Salmonella.
29 TLRs can detect a variety of extracellular
and endosomal PAMPs such as LPS, bacterial lipoproteins,
Figure2. The gastric innate immune response to Salmonella. (A) Following the invasion of the mucosa, the presence of Salmonella is detected by pattern
recognition receptors. Extracellular Salmonella are detected by Toll-like receptors inducing a transcriptional response leading to the expression of pro-
inflammatory cytokines such as IL-23. Intracellular Salmonella activate NOD-like receptors that can induce IL-23 expression, as well as the assembly of
NLRC4/NLRP3 inflammasomes that activate Caspase-1, promoting the secretion of mature IL-1b and IL-18. SPI-1 mediated activation of Caspase-1 in
epithelial cells might contribute to IL-18 secretion. (B) IL-18 and IL-23 amplify the inflammatory response by paracrine signaling. IL-18 induces the release
of IFNc from T cells, while IL-23 induces the release of IL-22 and IL-17. These cytokines induce the increased production of mucins and antimicrobial
peptides, and promote the release of CXC chemokines leading to an influx of neutrophils into the mucosa. (C) Infiltrating neutrophils are crucial for the
killing of extracellular Salmonellae. Although considered an intracellular pathogen, Salmonella can be found extracellularly following transcytosis
through M cells or after pyroptosis induced host cell lysis. Besides clearing the pathogen, neutrophil influx can also lead to damage to intestinal tissue,
resulting in the loss of epithelial cell barrier function and promoting diarrhea.
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peptidoglycan, flagellin DNA, RNA and others. Upon ligand
binding, TLRs engage the signaling adaptors MyD88 and TRIF,
which initiate signaling cascades leading to the activation of
the transcriptional factors NFkB and IRF3 that induce the
production of inflammatory cytokines (IL-8, IL-10, pro-IL-1β,
pro-IL18 and others) as well as a type I IFN response,
respectively.
29
In vitro, a multitude of TLRs can be activated by Salmonella-
derived ligands, such as lipoproteins (TLR1/2/6), LPS (TLR4),
the Salmonella flagellin FliC (TLR5) and CpG-rich repetitive
elements in Salmonella DNA (TLR9). In addition, TLR2 is
known to recognize CsgA, a subunit of the amyloid curly fibers
that form the biofilm matrix of S. typhimurium.
30 TLR4 and





2/2 mice have increased bacterial burdens in mesenteric
lymph nodes (MLNs) following oral infection.
31 Intriguingly,
Salmonella virulence seems to actually require TLR sensing. It
was recently shown that tlr4
2/2/tlr2
2/2 mice are sensitive to
Salmonella infection, but mice deficient in TLR2, TLR4 and
TLR9 are less sensitive.
32 This can be attributed to the fact that




fails to acidify. Since acidification is an important indicator
for Salmonella to sense the intra-phagosomal environment,




2/2 cells. Thus, although TLRs are clearly
essential for defense against pathogens, Salmonella has evolved
virulence mechanisms that are activated in response.
Salmonella flagellin is another PAMP sensed by PRRs. In the
gut, extracellular Salmonella flagellin is detected by enterocytes
expressing TLR5 on their basolateral surface, leading to NFkB
activation and a robust IL-8 inflammatory response.
33 Although
Salmonella has mechanisms to dampen this NFkB response, a
recent study revealed that enterocytes might have the ability
to bypass this effect by transmitting signals to neighboring
uninfected cells to promote NFkB-mediated IL-8 release in
response to Salmonella infection.
34
Once Salmonella has established itself within the SCV, it is
hidden from many extracellular detection mechanisms. Neverthe-
less, macrophages and other lymphocytes have evolved mechan-
isms to recognize the presence of PAMPs in the cytosol.
35 The
NOD-like receptor (NLR) family of PRR is a surveillance system
that can detect the presence of PAMPs in the cytosol. NLRs
contain an N-terminal protein-protein interaction domain [either
a Caspase Recruitment Domain (CARD) or a Pyrin-like domain
(PYD)], a central nucleotide oligomerization domain (NOD), and
a C-terminal Leucine-rich repeat domain (LRR).
35 Upon ligand
binding, NLRs multimerize and initiate different signaling
cascades. For example, NOD1 and NOD2 interact with RIP2
kinase, which is a potent activator of NFkB. The contribution
of NOD1/2 signaling to the innate immune defense against
Salmonella was recently shown by Geddes et al.
36 Mice deficient
in NOD1/2 or RIP2 showed attenuated inflammatory pathology,
reduced levels of inflammatory cytokines, and increased coloniza-
tion of the mucosal tissue. Interestingly, bone-marrow chimeras
demonstrated that this was dependent on NOD1/2 signaling in
hemopoietic as well as non-hemapoietic compartments.
In addition to NODs, there is a family of NLRs that do not
initiate a transcriptional program, but induce the assembly of a
large multiprotein signaling complex, called the inflammasome.
37
Assembly of the complex usually also requires an adaptor pro-
tein called ASC (apoptosis-associated speck-like protein with a
CARD), which recruits the cysteine protease pro-Caspase-1 to
the inflammasome.
35 Within this complex pro-Caspase-1 is
activated by dimerization and autoproteolytic cleavage.
38 Acti-
vated Caspase-1 cleaves the pro-forms of interleukin (IL)-1β and
IL-18, leading to production and secretion of the mature
cytokines. Caspase-1 activation also initiates a pro-inflammatory
cell-death program called pyroptosis. Pyroptosis is named for
“pyro” meaning fire and “ptosis” meaning to fall in Greek, which
reflects its hallmark inflammatory outcome.
39 Pyroptosis is similar
to apoptosis in that it is a programmed form of cell death
controlled by caspases. Pyroptosis is solely dependent on Caspase-
1. In contrast to apoptosis, pyroptosis is not a silent form of cell
death. During pyroptosis, there is formation of pores in the cell
membrane and subsequent release of cellular contents and pro-
inflammatory cytokines, which serve to amplify the inflammatory
response by signaling the recruitment of other mediators of
inflammation. Inflammasome-induced pyroptosis likely benefits
the host during microbial infections by eliminating the intra-
cellular niche of the pathogen and re-exposing it to extracellular
immune defenses.
40
S. typhimurium infections of bone marrow-derived macro-
phages in tissue culture rapidly activates NLRC4, a cytoplasmic
flagellin sensor, that initiates inflammasome assembly and
Caspase-1 activation.
41 The activation of the NLRC4 inflamma-
some requires the expression of the SPI-1 T3SS and flagellin.
These results led to the hypothesis that the SPI-1 needle complex,
which is evolutionarily related to the flagellar apparatus, was
accidentally translocating flagellin into the macrophage cyto-
sol.
42,43 However, Salmonellae deficient in flagellin are still
capable of inducing a NLRC4 inflammasome response, suggest-
ing that there was an additional NLRC4 ligand produced by
Salmonella. Subsequent studies revealed that PrgJ, the needle
complex rod protein, was also capable of stimulating the NLRC4
inflammasome.
44
Activated Caspase-1 is a very important mediator of the host
response to Salmonella. Mice lacking Caspase-1 are much more
sensitive to Salmonella infection and have higher bacterial burdens
in systemic organs compared with wild-type mice.
45,46 This is due
at least in part to the production of IL-1β and IL-18, since mice
lacking either cytokine are also more susceptible to Salmonella
infection than wild-type mice.
45 However, NLRC4-deficient mice
harbored comparable bacterial loads as wild-type mice following
oral infections with wild-type Salmonella.
46 The discrepancy
between the in vitro and in vivo findings was recently explained
by our results showing that Salmonellae can also activate Caspase-
1 through NLRP3, another cytosolic receptor of the NLR protein
family.
47 Salmonella grown to stationary phase, which results in
the downregulation of the SPI-1 T3SS and the expression of the
SPI-2 T3SS, activated two NLRs simultaneously: (1) NLRC4-
dependent cytokine release was stimulated by SPI-2 T3SS-
dependent translocation of flagellin. (2) NLRP3-dependent
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cytokine release is stimulated by an unknown ligand.
47 Consistent
with these results, NLRP3 and NLRC4 were shown to play
redundant roles in vivo since mice deficient in both NLRP3 and
NLRC4 had higher bacterial loads in MLN, spleen and liver,
similar to Caspase-1-deficient mice, while mice deficient in only
one NLR were comparable to wild-type mice.
47
Although in vitro infection models have established that
Salmonella flagellin is a potent activator of innate immune sensors
such as TLR5 and NLRC4, the importance of this recognition for
the different phases of a Salmonella infection remains unclear
because Salmonellae downregulate flagellin expression in vivo.
48,49
For example, Cummings et al. showed that FliC expression was
anatomically restricted in mice infected orally with S. typhimur-
ium, and fliC is expressed in the PP, but not in the mesenteric
lymph nodes and spleen.
49 In addition, flagellin-deficient
Salmonellae have been shown to have comparable virulence to
wild-type bacteria.
50,51 This downregulation of flagellin expression
appears to be an important virulence mechanism, since the growth
of Salmonellae constitutively overexpressing flagellin are highly
attenuated in a mouse model of infection.
52 Growth restriction
is most likely mediated by the NLRC4-Caspase-1 axis, since in
contrast to wild-type Salmonella, Salmonella overexpressing
flagellin are detected by NLRC4, a PRR that induces the
assembly of Caspase-1 activating inflammasome complexes in the
presence of flagellin in the cytoplasm.
40 Activation of Caspase-1
was suggested to induce pyroptosis of infected host macrophages,
release of the pathogen and subsequent neutrophil mediated
clearance.
40 Since NLRC4 plays a redundant role with NLRP3
in activating Caspase-1 in vivo, flagellin sensing by NLRC4 is
likely to be important for host defense early in the infection, most
likely in the GI tract where the bacteria still express flagellin.
However, during the systemic phase, NLRP3 recognizes intra-
cellular Salmonellae and mediates inflammasome-dependent
defense.
Mucosal inflammation during S. typhimurium infections. A
hallmark of S. typhimurium infections is an acute, mucosal
inflammation in the gut. This inflammation is a stereotypic host
response triggered by the detection of bacterial PAMPs within
the mucosa by PRRs and is induced in response to Salmonella
penetrating the intestinal epithelium and surviving in tissue
macrophages. Invasion and intracellular replication requires the
coordinated action of the two virulence-associated T3SSs called
SPI-1 and SPI-2. Consistently, both SPI-1 and SPI-2 were shown
to contribute to intestinal inflammation after oral infections of
calves or streptomycin pretreated mice.
53-55 In vitro infections
of cultured macrophages led to the identification of a variety of
mechanisms by which the host can recognize the presence of
S. typhimurium (see above). Activation of these PRRs leads to the
expression and secretion of key cytokines such as IL-18 and IL-23
(Fig.2A), which amplify the inflammatory response by paracrine
signaling mechanisms, inducing the massive secretion of IFNc,
IL-22 and IL-17 by mucosa-resident T cells (Fig.2B). In parti-
cular, IL-18, which is released in an inflammasome dependent
manner, is critical to induce T cells to secreted IFNc release in
vivo.
56 Consistently, Caspase-1-deficient mice are deficient for
gamma interferon expression in the murine cecum early (12 h)
after S. typhimurium infection.
57 Interestingly, IL-18 release in the
mucosa is independent of flagellin recognition since flagellin-
deficient S. typhimurium induce comparable levels of IL-18 and
IFNc
57. The nature of the ligand and the receptor inducing
Caspase-1 activation remains unknown thus far. Another major
inflammatory pathway in the mucosa is controlled by the release
of IL-23. The levels of IL-17 and IL-22 increase dramatically
within 2–5 h post-infection in bovine or avian ligated loops.
22,23
Such an early amplification of host inflammatory responses could
involve the stimulation of antigen-experienced T cells by IL-23,
inducing the release of IL-17 and IL-22. Consistently, IL-23
2/2
mice do not produce IL-17 and IL-22 in response to S. typhi-
murium infections.
17 In vitro, IL-23 is mainly produced by macro-
phages and dendritic cells, yet its source during S. typhimurium
infections remains unknown. In addition to T cells, Innate
Lymphoid Cells (ILCs), which include natural killer cells (NK
cells) and lymphoid tissue-inducer cells (LTi cells), could be
potential sources of IL-22.
58,59 In particular CD4
+ LTi cells play
a critical role in the development of lymphoid tissues and in
inflammatory responses. CD4
+ LTi cells have recently been
shown to be a major source of IL-22 production in response to
infections with C. rodentium.
60 This response was dependent on
IL-23 and was induced in response to Lymphoid toxin (LT), a
member of the Tumor Necrosis factor (TNF) core family that is
expressed mainly by lymphocytes, including T, B, NK and LTi
cells.
61,62 However, a role of LTi cells in S. typhimurium infections
remains to be demonstrated. Distinct T cell populations express
the IL-23 receptor on their surface, including Th17 cells, cdT
cells and NK T cells.
17,63-65 The combination of all of these
cytokines induces a strong inflammatory environment in the
intestine, which is characterized by an increased production of
anti-microbial peptides (IL-22/23 axis) and a recruitment of
neutrophils by the IL-17/23 axis, leading to diarrhea and the
deprivation of nutrients, which affects commensals as well as the
pathogen (Fig.2C).
Neutrophil influx during S. typhimurium infections. The
activation of innate immune responses in the mucosa and the
resulting inflammation serves as an activator of further innate
immune responses. One of these is the recruitment of neutro-
phils to the mucosa, which is mostly mediated via the IL-23/
IL-17 axis (Fig.2). The production of IL-17 stimulates the
secretion of CXC chemokines by intestinal epithelial cells and
granulopoiesis in the bone marrow by inducing the production
of G-CSF (granulocyte colony-stimulating factor).
66 Consistently,
IL-17-deficient mice have a severe defect in the recruitment of
neutrophils to the intestinal mucosa.
22 IL-1β production could
also contribute to neutrophil recruitment, since Caspase-1-
deficient mice exhibit reduced levels of CXC chemokines in the
cecal mucosa early after S. typhimurium infection.
57 The recruit-
ment of neutrophils is crucial to prevent the dissemination of
Salmonella from the gut, since neutropenia increases the risk of
systemic infections.
67,68 Although S. typhimurium is mainly con-
sidered an intracellular pathogen, the role of neutrophils in
containing the infection is likely to involve ingestion and killing
of extracellular bacteria.
69 Salmonella is susceptible to neutrophil-
mediated killing when it exits epithelial cells and transits to
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phagocytes or when it spreads to new host cells (Fig.2C).
Consistent with this idea, it has been shown recently that
Salmonellae constitutively expressing flagellin are released from
host cells via NLRC4/Caspase-1-induced pyroptosis and are
subsequently removed by neutrophils.
40 In addition, Salmonella
replicate extracellularly after depletion of neutrophils.
70 Although
neutrophils are important for host defense against Salmonella,
infiltrating neutrophils are also a major cause of tissue damage
in the mucosa, which is sometimes associated with necrosis in
large areas of the terminal ileum and colon.
53 This tissue damage
leads to a loss of epithelial barrier function, resulting in an
increase in inflammation and contributing to diarrhea. In
addition, neutrophils might contribute to diarrhea by stimulating
chloride secretion from epithelial cells.
71 Thus, although neutro-
phil recruitment prevents the systemic spread of the infection, it
might nevertheless be a key determinant for the development of
gastroenteritis.
Active induction of inflammation by S. typhimurium.
Although S. typhimurium cannot resist the onslaught of neutro-
phils in intestinal tissue, the pathogen appears to be custom-built
to bloom in the lumen of the inflamed intestine, because its
numbers in this niche increase dramatically during inflammation.
Above, we have discussed the different mechanisms Salmonella
has evolved to gain this advantage allowing it to survive and
replicate in the inflamed gut despite diarrhea and nutrient
restriction.
72 Considering the significant growth advantage that
Salmonella gains from intestinal inflammation, it would not be
surprising if Salmonella would actively induce host innate
immune pathways to cause inflammation. Indeed, the W.D.
Hardt and J.E. Galan research groups have recently published
studies that support such a mechanism.
73,74 Bruno et al. report
that infections of human epithelial cells induced a transcriptional
response through the activation of mitogen-activated protein
(MAP) kinase and NFkB signaling.
73 This activation was
dependent on the SPI-1 bacterial effector proteins SopE, SopE2
and SopB, and partially on the activation of Rho-family GTPase
Cdc42, but independent of intracellular sensors such as NOD1,
NOD2 and RIP2 kinase. In addition, S. typhimurium induced
intestinal inflammation in mice deficient for TLR4 and MyD88,
consistent with an active role of SPI-1 effectors in the activation of
innate immune responses.
73 In addition to a role in the activation
of NFkB signaling, SopE seems to also have a role in the
activation of Caspase-1.
74 Mueller et al. report that infection of
HeLa cells or RAW264 macrophages with wild-type S.
typhimurium or with a strain that expresses SopE and not
the other SPI-1 effectors induced the activation of Caspase-1, as
measured with the fluorescent Caspase-1 activity probe FLICA,
and IL-1β secretion.
74 This activation was independent of
flagellin, a known activator of the NLRC4/Caspase-1 axis.
75
Consistent with the in vitro findings, the effector-less mutant
expressing SopE induced intestinal inflammation in wild-type,
but not in Caspase-1-deficient mice. Similarly this strain failed
to induce inflammation in il-1R
2/2 and il-18
2/2 mice, again
supporting an important role of IL-18 in mucosal inflammation.
Finally, bone-marrow chimeras demonstrated that inflammation
induced by this effector-less mutant strain expressing SopE was
dependent on Caspase-1 expression in stromal but not lymphoid
cells, suggesting that SopE-induced Caspase-1 activation hap-
pened in gut epithelial cells and not mucosa resident lymphocytes.
Although these results suggest that T3SS effector proteins could
possibly activate Caspase-1 directly, the significance of these
results for infections with wild-type Salmonella is still unclear.
The effector-less mutant strain expressing SopE should be
compared with wild-type bacteria or to a SopE single deletion
mutant in the same analyses. In addition, several wild-type strains
of Salmonella lack SopE, yet are still able to induce activation of
Caspase-1. However, the notion that Caspase-1 could also be
active in stromal cells in the gut was recently strengthened by the
discovery of the NLRP6 inflammasome.
76 Unlike other NLRs,
NLRP6 is highly expressed in the epithelial cells of the intestine,
while its expression is low in lymphoid cells. NLRP6 seems to be
involved in gut homeostasis through Caspase-1 mediated IL-18
secretion.
76 The ligand activating NLRP6 remains undiscovered
so far, but it is hypothesized that it could be a bacterial PAMP
indicating epithelial cell integrity. Interestingly, IL-18 is an
important trigger of intestinal inflammation during Salmonella
infections, yet if Salmonellae activate NLRP6 in the gut and if
they do this actively by its T3SSs remains to be determined.
Summary and Outlook
In recent years, there has been a rapid increase in our under-
standing and appreciation of the importance, function and
mechanisms of the innate immune system. This includes
establishing the molecular basis for the detection of extra- and
intra-cellular pathogens by germline-encoded, pattern-recognition
receptors. These receptors play a crucial role in the GI tract in
recognizing the presence of invading pathogens and inducing
mucosal inflammation. Investigating Salmonella pathogenesis has
significantly contributed to our understanding of how pathogens
are detected in the gut and also how they respond to innate
immune defense mechanisms. A particularly interesting field of
study is how Salmonella has adapted to thrive in the gut despite
massive inflammation, illustrating how a pathogen has evolved
to trigger intestinal inflammation in order to outcompete the
intestinal microbiota. Recent reports have revealed fascinating
insights into how Salmonella takes advantage of the immune
responses in the mucosa and turns them in its favor. For example,
inflammation helps Salmonella to outcompete the microbiota
by ROS generating a novel respiratory electron acceptor, which
can be used by Salmonella but not the microbiota. In addition,
the detection of Salmonella by TLRs has been shown to be crucial
for Salmonella virulence, since it induces the acidification of
the phagosome, which in turn provides a cue for Salmonella
that it has reached its intracellular niche protected from extra-
cellular immune responses.
32 Finally, recent reports indicate that
Salmonella might have evolved the ability to actively trigger
NFkB and inflammasome signaling pathways through injected
effector proteins.
74
Despite these recent advances, we are only beginning to
decipher the role of different bacterial ligands, host pattern
recognition receptors and different cell types in directing the
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innate immune response to Salmonella. The recent discovery of
NLRs and the inflammasome has significantly expanded the
repertoire of possible innate immune detection mechanisms, yet
the function of most known NLRs remains undiscovered. In
addition, it has become clear that different cell types express a
distinct set of PRRs and might trigger a different inflammatory
program in response to pathogen infection. Finally, future
studies will also need to address how the different innate
immune responses shape adaptive immune responses and how this
influences Salmonella pathogenesis.
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